FROM EVERY ANGLE
HOW WE SUPPORT YOUR DECISIONS
Secondary research involves the investigation of secondary sources of data by…
We use this as a conclusive means to collect data through surveys, allowing us to…
We use this as as exploratory means when we need to determine what to expect, to…
Understanding your competitors’ development pipelines and clinical development…
Understanding the competitive landscape for late-stage pipeline assets and on-market…
Contracts & Tenders
We help describe, map and quantify the opportunity for tendering in different…
Gather a global perspective on the evolving competitor biosimilar and generic…
Whether in the US, EU or ROW, Lifescience Dynamics is expert in gathering intelligence…
Focused on primary research with key sources involved in the manufacture of products…
Therapy or product-focused evidence review…
Systematic review of commonly used tools in the Market Access and HTA areas…
Our pricing strategy research effective captures product value to maximize long-term…
WE OFFER CONSTANTLY EVOLVING SERVICES: EXPANSION TO EMERGING MARKETS AND INNOVATIVE RESEARCH SOLUTIONS
360° VIEW OF YOUR ASSETS
OUR SUCCESS IS ATTRIBUTED NOT ONLY TO THE QUALITY OF OUR PEOPLE, BUT TO OUR APPROACH, OUR ATTITUDE AND THE WAY WE TREAT OUR CLIENTS
The success we have achieved to date is down to our exceptional people. They all look, act and behave like ordinary people but every day they do extraordinary work for our clients globally. Our people are working for the world’s leading pharmaceutical, biotechnology, medical device and diagnostics companies on their toughest strategic and operational questions. Read more#
WHAT’S HAPPENING AT LIFESCIENCE
Market Research conferences
- PMRC USA, 5th–6th February 2020, Newark, NJ, USA
- Intellus USA, 29th April–1st May 2020, Philadelphia, PA, USA
- HSFA 24th Annual Scientific Meeting, 2nd–5th October 2020, Clevelend, OH, USA
Competitive Intelligence conferences
- Pharma CI Europe, 19th–20th March 2020, Zurich, Switzerland
- Pharma CI USA, 30th September–1st October 2020, Newark, NJ, USA
- EphMRA, 23rd–25th June 2020, Antwerp, Belgium
Market Access, Pricing & Reimbursements
- ISPOR Europe International Meeting, 14th–18th November 2020, Milan, Italy
Pharmaceutical decision support consultancy, Lifescience Dynamics, wins Queen’s Award for Enterprise for International Trade
- Consistent and sustainable growth based on overseas sales
- Success supports the trend in novel health technologies such as personalised, targeted, precision and regenerative medicines
- UK and European base critical to company’s success in global exports
[London, 21st April 2016] Lifescience Dynamics, a London headquartered decision support consultancy, has been awarded the prestigious Queen’s Award for Enterprise 2016 for International Trade. The business’ global network of opinion leaders, payers, researchers and expert consultants provides the pharmaceutical and life sciences industry with ‘unrivalled’ strategic insight and foresight to assist with difficult decision making, in complex and uncertain market conditions.
In the heavily regulated pharmaceutical environment, Lifescience Dynamics has the ability to engage with a vast, global network of experts to determine market opportunities that pharmaceutical companies cannot directly gather themselves. To this effect, Mr Rahmani has said:
“The success of the business is down to the team’s ability to gather market data and intelligence. To deliver actionable and impactful recommendations that are both impartial and considered. We are enablers that allow the world’s pharmaceutical businesses to see what’s around the corner.”
A changing healthcare environment
With so few blockbuster drugs on the horizon and many key disease areas well served by generics, innovation in the pharmaceutical market now focuses on precision and targeted medicine including biologics, regenerative and gene therapies.
“These novel treatments are expensive to discover, develop and produce, and it’s often uncertain who, how, and when anyone will pay for them,” says Rahmani. “In these niche markets, our pharmaceutical and biotech clients require a trusted partner for guidance. They are increasingly reliant on having a deep understanding of the market to ensure successful introduction of new pharmaceutical products.”
The company has seen exponential growth; having doubled in size from 2014 to 2015. 2016 is predicted to grow at a similar rate with offices planned for US expansion in Boston, Princeton and Chicago.
“It is an absolute honour to be acknowledged with the Queen’s Award,” says Rahmani. “We compete on a global level every day and we are winning.”
The success of Lifescience Dynamics’ recent growth correlates with the emphasis it places on hiring and training the best staff in the world. 75% of the organisation have PhDs and are recruited from the international pool of talent that is attracted to the UKs top universities. Rahmani attributes the fact that London is home to 10 of the top 100 universities, as a crucial success factor for Lifescience Dynamics.
For further information and to arrange interview opportunities with Lifescience Dynamics President, Rafaat Rahmani, please contact Ruth Delacour at ROAD Communications:
T. +44(0) 208 995 5832 / +44(0)7803 598838
Video footage interview with Rafaat Rahmani available on request
Lifescience Dynamics is a decision support firm helping life sciences companies (pharmaceutical, biotechnology, diagnostics and medical devices) with strategic insight and foresight to improve their assumptions, enabling them to make better decisions.
Since its inception in 2004, the firm has earned its reputation not only for providing actionable insights but also for their invaluable ability to anticipate future market trends. It is 100% independently owned and run by a team who consider customer satisfaction to be their core driver.
Lifescience Dynamics work across three practice areas:
Market research (qualitative and quantitative)
Competitive intelligence (primary and secondary research)
Market access, pricing and reimbursement
In the summer of 2004, Rafaat founded Lifescience Dynamics. He had a vision of what would make an effective global decision support service, dedicated exclusively to pharmaceutical and biotechnology industries. It would have to be the best in class market research, competitive intelligence and market access, combined with first-rate people and a business model that met their clients’ global requirements. Lifescience Dynamics is privileged to be able to boast an extraordinary worldwide customer base, supporting clients from top 20 pharmaceutical companies through to smaller niche pharma and biotech firms. Rafaat prides himself in his dedication to his clients: “Revenue is important, but customer experience is even more crucial” is a motto reflected in everything the company does.